The abstract is read at the publisher; the summary is JClub's.
Palmitic acid exposure (100 M for 24 hours) in human podocytes increases WT1 and TGF-β1 signaling while driving abortive cell-cycle re-entry and podocyte phenotype loss.
- Why it matters: Obesity-related glomerulopathy involves podocyte injury and secondary focal segmental glomerulosclerosis, but the lipid-specific mechanisms linking palmitic acid to podocyte dysfunction are unclear.
- What they did: Human podocytes were treated with palmitic acid and assessed for lipid accumulation, WT1 expression/promoter activity, TGF-β1/Smad2 signaling, and cell-cycle regulators; mice on a high-fat diet for 16 weeks were analyzed in podocyte-enriched glomeruli.
- The result: Palmitic acid caused cytoskeletal abnormalities, reduced podocyte structural genes, and upregulated fibronectin, collagen, and α-SMA; about ~30% of treated podocytes became binucleated without podocyte number increase, paralleling TGF-β1 activation and glomerulosclerosis in HFD mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.